Last updated: 2026-09-06 03:10:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
HeartSciences Inc. (HSCS) operates in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector and is listed on NASDAQ. The stock is currently priced at $3.71, with a market capitalisation of $13.56M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.63 to $3.80. This page covers its latest market performance, valuation, price trends and company information.
$13.56M | |
$3.34 | |
$600.00 | |
$1.63 | |
$3.36 | |
171.28K | |
-- | |
-- | |
$3.80 | |
$1.63 | |
-- | |
-- |
HeartSciences Inc. (HSCS) last closed at $3.36 as of 2026-09-05 00:00:00, unchanged from the previous close of $3.36.
During the latest regular trading session, HSCS traded between $1.63 and $600.00, with a volume of 171.28K shares. The closing price was near the lower end and near the upper end of its 52-week range.
Over the past seven days, HeartSciences Inc. (HSCS) moved from $3.01 to $3.71, representing a gain of 23.09% ($0.70).
The stock traded between $3.17 and $3.79 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 102.02 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 95.6%
HSCS is currently trading at $3.71, placing it 95.6% of the way from its 52-week low of $1.63 to its 52-week high of $3.80. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.
| Industry | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
| Employees | 14 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of HeartSciences Inc. (HSCS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.